JP2007517758A - 新規材料およびその製造方法 - Google Patents
新規材料およびその製造方法 Download PDFInfo
- Publication number
- JP2007517758A JP2007517758A JP2006548369A JP2006548369A JP2007517758A JP 2007517758 A JP2007517758 A JP 2007517758A JP 2006548369 A JP2006548369 A JP 2006548369A JP 2006548369 A JP2006548369 A JP 2006548369A JP 2007517758 A JP2007517758 A JP 2007517758A
- Authority
- JP
- Japan
- Prior art keywords
- silicon
- phosphorus
- composite material
- sample
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 239000000463 material Substances 0.000 title description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 213
- 239000010703 silicon Substances 0.000 claims abstract description 208
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 207
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 190
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 163
- 239000011574 phosphorus Substances 0.000 claims abstract description 163
- 238000000034 method Methods 0.000 claims abstract description 63
- 238000006243 chemical reaction Methods 0.000 claims abstract description 23
- 239000002131 composite material Substances 0.000 claims description 118
- 239000011856 silicon-based particle Substances 0.000 claims description 30
- 238000001959 radiotherapy Methods 0.000 claims description 15
- 206010028980 Neoplasm Diseases 0.000 claims description 14
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 8
- 201000011510 cancer Diseases 0.000 claims description 6
- 239000002210 silicon-based material Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 description 31
- 239000000203 mixture Substances 0.000 description 29
- 238000010438 heat treatment Methods 0.000 description 24
- 239000010410 layer Substances 0.000 description 23
- 239000000843 powder Substances 0.000 description 21
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 16
- 238000001704 evaporation Methods 0.000 description 12
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 230000008020 evaporation Effects 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- 239000010453 quartz Substances 0.000 description 8
- 125000004429 atom Chemical group 0.000 description 7
- 238000002725 brachytherapy Methods 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- 239000007943 implant Substances 0.000 description 7
- 239000012535 impurity Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000005530 etching Methods 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
- 238000007743 anodising Methods 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 239000002019 doping agent Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000011859 microparticle Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000011863 silicon-based powder Substances 0.000 description 4
- 239000004254 Ammonium phosphate Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229910000676 Si alloy Inorganic materials 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 3
- 235000019289 ammonium phosphates Nutrition 0.000 description 3
- 229910052788 barium Inorganic materials 0.000 description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 3
- 229910052790 beryllium Inorganic materials 0.000 description 3
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009689 gas atomisation Methods 0.000 description 3
- 239000010439 graphite Substances 0.000 description 3
- 229910002804 graphite Inorganic materials 0.000 description 3
- 238000005468 ion implantation Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229910021426 porous silicon Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229910052712 strontium Inorganic materials 0.000 description 3
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229910052582 BN Inorganic materials 0.000 description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 2
- 229910052684 Cerium Inorganic materials 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Chemical class 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001223 polyethylene glycol Chemical class 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000009692 water atomization Methods 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 229910001096 P alloy Inorganic materials 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012615 aggregate Substances 0.000 description 1
- 229910021417 amorphous silicon Inorganic materials 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 229910021419 crystalline silicon Inorganic materials 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 239000008010 parenteral excipient Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/02—Silicon
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B31/00—Diffusion or doping processes for single crystals or homogeneous polycrystalline material with defined structure; Apparatus therefor
- C30B31/06—Diffusion or doping processes for single crystals or homogeneous polycrystalline material with defined structure; Apparatus therefor by contacting with diffusion material in the gaseous state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B15/00—Single-crystal growth by pulling from a melt, e.g. Czochralski method
- C30B15/02—Single-crystal growth by pulling from a melt, e.g. Czochralski method adding crystallising materials or reactants forming it in situ to the melt
- C30B15/04—Single-crystal growth by pulling from a melt, e.g. Czochralski method adding crystallising materials or reactants forming it in situ to the melt adding doping materials, e.g. for n-p-junction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Silicon Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Glass Compositions (AREA)
- Radiation-Therapy Devices (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Inorganic Fibers (AREA)
Abstract
Description
(ai)シリコンサンプルの少なくとも一部を900℃から1500℃のシリコン反応温度に加熱するステップと、
(bi)リンサンプルの少なくとも一部を加熱して、リン蒸気が生成され、かつリンサンプルの少なくとも一部が100℃から800℃のリン蒸発温度に加熱されるステップと、
(ci)リン蒸気の少なくとも一部をシリコン反応温度に加熱されたシリコンサンプルの少なくとも一部と接触させることを可能にする、および/または引き起こすステップとを含み、
ステップ(ai)、(bi)、(ci)が行なわれて、シリコンおよびリンを含む溶融複合材料が形成される、シリコンおよびリンを含む複合材料を製造する方法を提供する。
(aii)リンサンプルを取るステップと、
(bii)リンサンプルをシリコン層で実質的に包囲するステップと、
(cii)シリコン層の少なくとも一部とリンサンプルの間で温度差が設定され、かつリンの少なくとも一部が蒸発されるように、シリコンに熱を加えるステップと、
(dii)シリコンおよびリンを含む溶融複合材料が形成されるように、リン蒸気の少なくとも一部をシリコン層の少なくとも一部と接触させることを可能にする、および/または引き起こすステップとを含む。
(aiii)液状シリコンリン化物が形成されるような温度および圧力で、固体シリコンの第1のサンプルとリン蒸気の第1のサンプルを化合するステップと、
(biii)シリコンおよびリンを含む複合材料が形成されるように、液状のシリコンリン化物をシリコンの第2のサンプルおよび/またはリンの第2のサンプルと化合させることを可能にする、および/または引き起こすステップとを含む。
(aiv)熱源とリンサンプルの間にシリコンの第1のサンプルを配置し、リンサンプルが、シリコンの第1のサンプルによって熱源から隔離されるステップと、
(biv)熱源を使用して、リンサンプルの少なくとも一部を加熱して、リンのサンプルの少なくとも一部が蒸発されるステップと、
(civ)シリコンおよびリンを含む溶融複合材料が形成されるように、リン蒸気の少なくとも一部をシリコンの第1のサンプルの少なくとも一部および/またはシリコンの第2のサンプルと化合させるステップとを含む。
(av)リンサンプルの少なくとも一部を蒸発させるステップと、
(bv)リン蒸気の少なくとも一部が位置する範囲に、リンの複数の粒子を添加するステップと、
(cv)シリコンおよびリンを含む溶融複合材料が形成されるように、900℃から1500℃の温度にシリコン粒子を加熱するステップとを含む。
(avi)揮発性元素のサンプルを取るステップと、
(bvi)揮発性元素のサンプルをシリコン層で実質的に包囲するステップと、
(cvi)シリコン層の少なくとも一部と揮発性元素のサンプルとの間に温度差が設定され、かつ揮発性元素の少なくとも一部が蒸発されるように、シリコンに熱を加えるステップと、
(dvi)シリコンおよび揮発性元素を含む複合材料が形成されるように、揮発性元素の蒸気の少なくとも一部をシリコン層の少なくとも一部と接触させることを可能にする、および/または引き起こすステップとを含む。
本発明の実施において、傾斜炉(図示せず)、および図1に示される改質された炉の、2つの異なる炉が使用される。
セクション(A)に記載された上記方法に起因する、シリコン粉末の形態のシリコンおよびリンを含む複合材料は、31Pの中性子変換をもたらす原子炉中で熱中性子照射にさらされた。放射条件は、合金内で32Pの生成を最大限にするために選択される。中性子の捕捉によって、32Pの形成がもたらされる。
31P+n0=32P
本発明による放射線治療製品は、皮下、筋肉内、腹腔内または表皮技術による投与に適切な、様々な形態を有してもよい。
Claims (8)
- リンおよびシリコンを含む複合材料を製造する方法であって、
(a)リンサンプルを取るステップと、
(b)リンサンプルを、多数のシリコン粒子を含むシリコン層で実質的に包囲するステップと、
(c)シリコン層の少なくとも一部とリンサンプルの間で温度差が設定され、かつリンの少なくとも一部が蒸発するように、シリコンに熱を加えるステップと、
(d)シリコンおよびリンを含む溶融複合材料が形成されるように、リン蒸気の少なくとも一部をシリコン層の少なくとも一部と接触させることを可能にする、および/または引き起こすステップと
を含む、方法。 - ステップ(a)、(b)、(c)が、シリコン層の少なくとも一部が900℃から1500℃のシリコン反応温度に加熱されるように行なわれることを特徴とする、請求項1に記載の方法。
- リンサンプルが赤リンを含むことを特徴とする、請求項1に記載の方法。
- さらに、ステップ(d)によって生成された溶融複合材料の少なくとも一部を霧化する、ステップ(e)を含むことを特徴とする、請求項1に記載の方法。
- さらに、ステップ(e)で形成された複合材料の少なくとも一部を、(fi)冷却するステップと(fii)多孔化するステップとを含むことを特徴とする、請求項4に記載の方法。
- さらに、(fii)で製造された複合材料の少なくとも一部に中性子を照射して、リンの少なくとも一部が32Pに変換されるステップ(g)を含むことを特徴とする、請求項5に記載の方法。
- 請求項6に記載の方法によって得られる、放射線治療製品。
- 癌の治療に使用される、請求項7に記載の放射線治療製品。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0400149.1 | 2004-01-06 | ||
GB0400149A GB2409924A (en) | 2004-01-06 | 2004-01-06 | Method of making a silicon-phosphorus composite |
PCT/GB2004/005243 WO2005066073A1 (en) | 2004-01-06 | 2004-12-15 | New material and method of fabrication therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007517758A true JP2007517758A (ja) | 2007-07-05 |
JP4896740B2 JP4896740B2 (ja) | 2012-03-14 |
Family
ID=31503457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006548369A Active JP4896740B2 (ja) | 2004-01-06 | 2004-12-15 | 新規材料およびその製造方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8293630B2 (ja) |
EP (1) | EP1704118B1 (ja) |
JP (1) | JP4896740B2 (ja) |
KR (1) | KR101170890B1 (ja) |
CN (1) | CN100537424C (ja) |
AT (1) | ATE552213T1 (ja) |
DK (1) | DK1704118T3 (ja) |
GB (1) | GB2409924A (ja) |
RU (1) | RU2423148C2 (ja) |
WO (1) | WO2005066073A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011088798A (ja) * | 2009-10-26 | 2011-05-06 | Sino-American Silicon Products Inc | シリコン結晶体成形装置 |
JP2013118223A (ja) * | 2011-12-01 | 2013-06-13 | Ulvac Japan Ltd | 結晶太陽電池の製造方法及び結晶太陽電池 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1643568A1 (de) * | 2004-10-04 | 2006-04-05 | Novaled GmbH | Verfahren zum Herstellen einer Schicht aus einem dotierten Halbleitermaterial und Vorrichtung |
ES2669585T3 (es) | 2004-10-29 | 2018-05-28 | The Regents Of The University Of California | Micropartículas porosas de silicio para la entrega de fármaco para el ojo |
KR20170084358A (ko) * | 2007-07-10 | 2017-07-19 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 선택된 조직에 조성물을 전달하는 물질 및 방법 |
US10350431B2 (en) | 2011-04-28 | 2019-07-16 | Gt Medical Technologies, Inc. | Customizable radioactive carriers and loading system |
US9492683B2 (en) | 2013-03-15 | 2016-11-15 | Gammatile Llc | Dosimetrically customizable brachytherapy carriers and methods thereof in the treatment of tumors |
US9821174B1 (en) | 2015-02-06 | 2017-11-21 | Gammatile Llc | Radioactive implant planning system and placement guide system |
WO2017008059A1 (en) | 2015-07-09 | 2017-01-12 | The Regents Of The University Of California | Fusogenic liposome-coated porous silicon nanoparticles |
US10290752B1 (en) * | 2016-05-04 | 2019-05-14 | St3 Llc | Methods of doping semiconductor materials and metastable doped semiconductor materials produced thereby |
CN105870434B (zh) * | 2016-06-06 | 2019-12-20 | 南昌大学 | 一种硅粉掺杂的方法 |
US10888710B1 (en) | 2016-11-29 | 2021-01-12 | Gt Medical Technologies, Inc. | Transparent loading apparatus |
US10981018B2 (en) | 2019-02-14 | 2021-04-20 | Gt Medical Technologies, Inc. | Radioactive seed loading apparatus |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH029705A (ja) * | 1987-11-27 | 1990-01-12 | Ethyl Corp | 高い純度のドーピング合金 |
WO1998027246A1 (en) * | 1996-12-18 | 1998-06-25 | Implant Sciences Corp. | Sputter cathode for application of radioactive material |
US5926727A (en) * | 1995-12-11 | 1999-07-20 | Stevens; Gary Don | Phosphorous doping a semiconductor particle |
JPH11510469A (ja) * | 1995-08-03 | 1999-09-14 | イギリス国 | 生体用材料 |
EP1211223A1 (fr) * | 2000-12-04 | 2002-06-05 | Invensil | Fabrication de silicium dopé par ajout de phosphore et destiné à la préparation des alkyl ou aryl-halogenosilanes |
WO2002067998A2 (en) * | 2001-02-22 | 2002-09-06 | Psimedica Limited | Devices and methods for the treatment of cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4789501A (en) * | 1984-11-19 | 1988-12-06 | The Curators Of The University Of Missouri | Glass microspheres |
NO165288C (no) * | 1988-12-08 | 1991-01-23 | Elkem As | Silisiumpulver og fremgangsmaate for fremstilling av silisiumpulver. |
JPH07211665A (ja) | 1994-01-20 | 1995-08-11 | Matsushita Electron Corp | シリコン結晶中へのリンの拡散方法および不純物源 |
US5894133A (en) * | 1996-12-18 | 1999-04-13 | Implant Science Corporation | Sputter cathode for application of radioactive material |
-
2004
- 2004-01-06 GB GB0400149A patent/GB2409924A/en not_active Withdrawn
- 2004-12-15 KR KR1020067013501A patent/KR101170890B1/ko active IP Right Grant
- 2004-12-15 DK DK04806058.6T patent/DK1704118T3/da active
- 2004-12-15 EP EP04806058A patent/EP1704118B1/en active Active
- 2004-12-15 AT AT04806058T patent/ATE552213T1/de active
- 2004-12-15 CN CNB2004800399035A patent/CN100537424C/zh active Active
- 2004-12-15 WO PCT/GB2004/005243 patent/WO2005066073A1/en active Application Filing
- 2004-12-15 RU RU2006128584/15A patent/RU2423148C2/ru active
- 2004-12-15 JP JP2006548369A patent/JP4896740B2/ja active Active
- 2004-12-15 US US10/585,324 patent/US8293630B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH029705A (ja) * | 1987-11-27 | 1990-01-12 | Ethyl Corp | 高い純度のドーピング合金 |
JPH11510469A (ja) * | 1995-08-03 | 1999-09-14 | イギリス国 | 生体用材料 |
US5926727A (en) * | 1995-12-11 | 1999-07-20 | Stevens; Gary Don | Phosphorous doping a semiconductor particle |
WO1998027246A1 (en) * | 1996-12-18 | 1998-06-25 | Implant Sciences Corp. | Sputter cathode for application of radioactive material |
EP1211223A1 (fr) * | 2000-12-04 | 2002-06-05 | Invensil | Fabrication de silicium dopé par ajout de phosphore et destiné à la préparation des alkyl ou aryl-halogenosilanes |
WO2002067998A2 (en) * | 2001-02-22 | 2002-09-06 | Psimedica Limited | Devices and methods for the treatment of cancer |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011088798A (ja) * | 2009-10-26 | 2011-05-06 | Sino-American Silicon Products Inc | シリコン結晶体成形装置 |
JP2013118223A (ja) * | 2011-12-01 | 2013-06-13 | Ulvac Japan Ltd | 結晶太陽電池の製造方法及び結晶太陽電池 |
Also Published As
Publication number | Publication date |
---|---|
CN1902130A (zh) | 2007-01-24 |
EP1704118B1 (en) | 2012-04-04 |
US8293630B2 (en) | 2012-10-23 |
DK1704118T3 (da) | 2012-07-23 |
US20070190761A1 (en) | 2007-08-16 |
KR101170890B1 (ko) | 2012-08-06 |
WO2005066073A1 (en) | 2005-07-21 |
RU2006128584A (ru) | 2008-02-20 |
GB2409924A (en) | 2005-07-13 |
EP1704118A1 (en) | 2006-09-27 |
RU2423148C2 (ru) | 2011-07-10 |
CN100537424C (zh) | 2009-09-09 |
GB0400149D0 (en) | 2004-02-11 |
ATE552213T1 (de) | 2012-04-15 |
KR20070001091A (ko) | 2007-01-03 |
JP4896740B2 (ja) | 2012-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4896740B2 (ja) | 新規材料およびその製造方法 | |
EP1844794B1 (en) | Silicon implants comprising a radionucleotide and/or a cytotoxic drug and their use in cancer treatment | |
Raineri et al. | He-vacancy interactions in Si and their influence on bubble formation and evolution | |
AU2002233513A1 (en) | Devices and methods for the treatment of cancer | |
Nakahira et al. | Biocompatibility of dense hydroxyapatite prepared using an SPS process | |
JP2002539068A (ja) | 結晶成長工程に使用される溶融シリコンのバリウムドーピング | |
Obata et al. | Electrical polarization of bioactive glass and assessment of their in vitro apatite deposition | |
Filius et al. | The retention of Ar in low energy high fluence Ar-irradiated Mo and Si | |
JP2002539069A (ja) | 結晶成長法に使用される溶融シリコンのストロンチウムドーピング | |
Prins | Improved activation of boron-dopant atoms implanted into diamond | |
RU2193080C2 (ru) | Способ ионного легирования твердых тел | |
JP2000054009A (ja) | 合金粉末の製造方法及びそれを用いた熱電素子の製造方法 | |
RU2170645C2 (ru) | Шихта для изготовления носителя клеточных структур | |
Heera | Comment on ‘‘Evidence of enhanced epitaxial crystallization at low temperature by inelastic electronic scattering of mega‐electron‐volt heavy‐ion‐beam irradiation’’[J. Appl. Phys. 79, 682 (1996)] | |
Chen et al. | SiC/SiC Composites Irradiation Behaviour in Fusion Reactor Environment Conditions | |
Mee | Observations of electron-beam-induced thermal effects in amorphous Se80As20 and Se64As16Au20 thin films | |
Ellingboe et al. | Implantation-induced defects in high-dose O-implanted Si | |
JPH05208919A (ja) | 放射線治療用微小ガラスとその製造方法 | |
Savin | The Structure of E93-Type Phases in the Ni-Nb System | |
Prots et al. | The crystal structure of the novel ternary silicide Sm4Pd4Si3 | |
Reichel et al. | Fundamentals of Flash Lamp Annealing of Shallow Boron-Doped Silicon | |
Allen et al. | In Situ Study of the Effects of Heavy-Ion Irradiation on Co-Evaporated Cosi2 Films | |
Lindner et al. | High-energy high-dose Ni irradiation of SOI structures | |
Shimomura et al. | 4.4 Damage evolution in high energy ion-irradiated metals and the | |
Didyk et al. | Track effects in silicon irradiated by swift high energy heavy ions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101122 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110216 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110223 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110520 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110614 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110912 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110920 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111121 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111213 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111221 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4896740 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150106 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |